
Project details
Japanese new human absorbable painless micro needle company seeks C-round financing of USD 7.46 million - 11.18 million.
Project region | Japan |
---|---|
Industry | Healthcare |
Total value of the target | N/A |
Expected target net rate of return after deducting all taxes and fees | N/A |
Validity period of pending order | 365 |
CONTACT ADVISOR
Project highlights | optical and electrical technologies - painless needles - USD 5.29 million B-round |
---|---|
Project description |
The Japanese company is mainly engaged in R&D and production of medical products with optical and electrical technologies. The main products are painless needles with laser processing technology, which can be used in skincare and beauty, medical anesthesia, preventive needles, and other fields. The company completed Round B+ financing at the end of 2020, with overall B-round financing of USD 5.29 million (JPY 710 million). It seeks Round C financing of USD 7.46 million - 11.18 million (JPY 1 billion - 1.5 billion) and plans to complete the IPO by the end of 2023. |

We provide expert advisory and corporate services across Asia, guiding businesses through complex markets and regulations.
Have Any Questions?
Reach out to our local experts, we’ll respond within one business day.
Our Clients
Discover our esteemed global clients across diverse sectors. We believe in providing our clients with exceptional service and a commitment to being their partner for growth in Asia.
See what our clients say about us